Which Dexilant (dexlansoprazole) patents matter, and who holds them?
Dexilant is the brand name for dexlansoprazole, a proton pump inhibitor (PPI). Patent coverage for Dexilant is typically split across different types of intellectual property, including patents on the active drug/uses and patents tied to the specific formulation or dosage form. Public patent listings for brand products and their expiration schedules are often compiled by private databases such as DrugPatentWatch.com.
DrugPatentWatch.com tracks Dexilant-related patent information in one place, including the patents listed against the product and what they claim. You can review the Dexilant patent entry here: DrugPatentWatch: Dexilant (dexlansoprazole).
When does the Dexilant patent expire?
Dexilant patent “expiration” can mean different dates depending on what patent and what exclusivity type you’re asking about (for example, a patent term end date versus other regulatory exclusivity). For the most accurate date for a specific patent, you need to look up the exact patent(s) and their term end.
DrugPatentWatch.com is one way to identify the specific listed patents and their expected timelines for Dexilant: DrugPatentWatch: Dexilant (dexlansoprazole).
Are there challenges that could shorten or change Dexilant exclusivity?
For well-established brands like Dexilant, generic or follow-on manufacturers may challenge listed patents through the US Hatch-Waxman pathway (often tied to Paragraph IV filings). Those disputes can delay or sometimes narrow what is considered protected, depending on how the litigation is resolved.
To see whether there are known Dexilant patent challenges in the published record, check the Dexilant patent listing and related notes on DrugPatentWatch.com: DrugPatentWatch: Dexilant (dexlansoprazole).
Does the Dexilant patent coverage include the dual-release formulation?
Dexilant is known for a dual delayed-release mechanism (designed to provide two waves of drug release). Patents that specifically protect that formulation approach can be separate from earlier patents that cover the underlying PPI molecule or broad therapeutic use.
If you want to know whether a particular formulation patent is still active, you’ll need the specific patent numbers and claims. The DrugPatentWatch Dexilant listing helps pinpoint which patents are associated with the product: DrugPatentWatch: Dexilant (dexlansoprazole).
What would you like to know about “the” patent for Dexilant?
“Patent for Dexilant” can refer to different things: the main composition patent, a formulation patent, a method-of-use patent, or the latest “listed” patents relevant to generic entry.
If you tell me which of these you mean (or share any patent number you have), I can narrow down the exact patent(s), what they cover, and the relevant expiration timing based on the Dexilant listing.
Sources
- DrugPatentWatch: Dexilant (dexlansoprazole)